Correlation Between Golden Biotechnology and CHC Healthcare

Can any of the company-specific risk be diversified away by investing in both Golden Biotechnology and CHC Healthcare at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Golden Biotechnology and CHC Healthcare into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Golden Biotechnology and CHC Healthcare Group, you can compare the effects of market volatilities on Golden Biotechnology and CHC Healthcare and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Golden Biotechnology with a short position of CHC Healthcare. Check out your portfolio center. Please also check ongoing floating volatility patterns of Golden Biotechnology and CHC Healthcare.

Diversification Opportunities for Golden Biotechnology and CHC Healthcare

0.27

Correlation Coefficient

Golden Biotechnology  CHC Healthcare

Modest diversification

The 3 months correlation between Golden and CHC is 0.27. Overlapping area represents the amount of risk that can be diversified away by holding Golden Biotechnology and CHC Healthcare Group in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on CHC Healthcare Group and Golden Biotechnology is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Golden Biotechnology are associated (or correlated) with CHC Healthcare. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of CHC Healthcare Group has no effect on the direction of Golden Biotechnology i.e., Golden Biotechnology and CHC Healthcare go up and down completely randomly.

Pair Corralation between Golden Biotechnology and CHC Healthcare

Assuming the 90 days trading horizon Golden Biotechnology is expected to under-perform the CHC Healthcare. In addition to that, Golden Biotechnology is 1.45 times more volatile than CHC Healthcare Group. It trades about -0.21 of its total potential returns per unit of risk. CHC Healthcare Group is currently generating about 0.03 per unit of volatility. If you would invest  3,990  in CHC Healthcare Group on September 23, 2024 and sell it today you would earn a total of  25.00  from holding CHC Healthcare Group or generate 0.63% return on investment over 90 days.

Time Period	3 Months [change]
Direction	Moves Together
Strength	Very Weak
Accuracy	100.0%
Values	Daily Returns

Golden Biotechnology  vs.  CHC Healthcare Group

Golden Biotechnology

Risk-Adjusted Performance

0 of 100

Very Weak

Over the last 90 days Golden Biotechnology has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of abnormal performance in the last few months, the Stock's basic indicators remain fairly stable which may send shares a bit higher in January 2025. The latest fuss may also be a sign of long-term up-swing for the venture sophisticated investors.

CHC Healthcare Group

Risk-Adjusted Performance

0 of 100

Very Weak

Over the last 90 days CHC Healthcare Group has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of fairly stable basic indicators, CHC Healthcare is not utilizing all of its potentials. The latest stock price fuss, may contribute to near-short-term losses for the sophisticated investors.

Pair Trading with Golden Biotechnology and CHC Healthcare

The main advantage of trading using opposite Golden Biotechnology and CHC Healthcare positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Golden Biotechnology position performs unexpectedly, CHC Healthcare can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in CHC Healthcare will offset losses from the drop in CHC Healthcare's long position.

The idea behind Golden Biotechnology and CHC Healthcare Group pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Price Ceiling Movement module to calculate and plot Price Ceiling Movement for different equity instruments.